Contract with Customer, Liability, Current in USD of Ernexa Therapeutics Inc. from Q4 2018 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
Ernexa Therapeutics Inc. quarterly Contract with Customer, Liability, Current history and change rate from Q4 2018 to Q1 2025.
  • Ernexa Therapeutics Inc. Contract with Customer, Liability, Current for the quarter ending 31 Mar 2025 was $5.34M.
Contract with Customer, Liability, Current, Quarterly (USD)
Contract with Customer, Liability, Current, YoY Quarterly Change (%)

Ernexa Therapeutics Inc. Quarterly Contract with Customer, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2025 $5.34M 31 Mar 2025 10-Q 07 May 2025
Q4 2020 $76K -$384K -83.5% 31 Dec 2020 10-K 11 Mar 2021
Q3 2020 $120K -$623K -83.8% 30 Sep 2020 10-Q 13 Nov 2020
Q2 2020 $377K -$141K -27.2% 30 Jun 2020 10-Q 07 Aug 2020
Q1 2020 $383K -$811K -67.9% 31 Mar 2020 10-Q 20 May 2020
Q4 2019 $460K -$911K -66.4% 31 Dec 2019 10-K 19 Mar 2020
Q3 2019 $743K 30 Sep 2019 10-Q 01 Nov 2019
Q2 2019 $518K 30 Jun 2019 10-Q 12 Aug 2019
Q1 2019 $1.19M 31 Mar 2019 10-Q 14 May 2019
Q4 2018 $1.37M 31 Dec 2018 10-K 22 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.